Staff Reporter
,
Singapore
Photo from Singapore-MIT Alliance for Research and Technology (SMART) website
The device enables real-time analysis using a single drop of blood.
Researchers from the Singapore-MIT Alliance for Research and Technology and KK Women’s and Children’s Hospital have developed a diagnostic device capable of profiling newborns’ immune function using a single drop of blood.
The device, named BiophysicaL Immune Profiling for Infants (BLIPI), is designed to deliver real-time analysis of immune responses for early detection of severe inflammatory conditions in newborns, including those in neonatal intensive care units.
BLIPI is portable and can be used directly at the patient’s bedside, intended to improve access to immune profiling in hospital settings and resource-limited environments.
Future studies will involve larger clinical trials to validate the BLIPI’s diagnostic accuracy across different neonatal age groups and conditions.
In addition, the research team plans to refine the device for broader clinical adoption.
Join
Healthcare Asia Magazine
community
Since you’re here…
…there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.
We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.
Let us help you drive your business forward with a good partnership!
